[Other] Meaningful Endpoints for Idiopathic Pulmonary Fibrosis (IPF) Clinical Trials: Emphasis on 'Feels, Functions, Survives'

Closed

leyderjl1997 Post time 2024-2-2 00:10:35 | Show all posts |Read mode

Reward60points

journal：American Journal of Respiratory and Critical Care Medicine

Authors：Ganesh Raghu; Marya Ghazipura; Thomas R. Fleming; Kerri I Aronson; Jürgen Behr; Kevin K Brown; Kevin R. Flaherty; Ella A Kazerooni; Toby M Maher; Luca Richeldi; Joseph A. Lasky; Jeffrey J Swigris; Robert Busch; Lili Garrard; Dong-Hyun Ahn; Ji Li; Khalid Puthawala; Gabriela Rodal; Sally Seymour; Nargues Weir; Sonye K. Danoff; Neil Ettinger; Jonathan Goldin; Marilyn K Glassberg; Leticia Kawano-Dourado; Nasreen Khalil; Lisa Lancaster; David A. Lynch; Yolanda Mageto; Imre Noth; Jessica E Shore; Marlies Wijsenbeek; Robert Brown; Daniel Grogan; Dorothy Ivey; Patrycja Golinska; Banu A. Karimi-Shah; Fernando J. Martinez

Published date：--

DOI：10.1164/rccm.202312-2213so

PDF link：https://www.atsjournals.org/doi/pdf/10.1164/rccm.202312-2213SO

Article link：http://dx.doi.org/10.1164/rccm.202312-2213so

Article Source：American Thoracic Society。

Remark：

You can support us by donating, we would be very grateful.

Reply

Use magic Donate Report

All Reply0 Show all posts

Reply

leyderjl1997 Lv.3

Intermediate member

post
reply
points
346

[Other] Meaningful Endpoints for Idiopathic Pulmonary Fibrosis (IPF) Clinical Trials: Emphasis on 'Feels, Functions, Survives'

Reply

Same Category

Latest Reply

Announcement

Enthusiastic users today

[Other] Meaningful Endpoints for Idiopathic Pulmonary Fibrosis (IPF) Clinical Trials: Emphasis on 'Feels, Functions, Survives' Copy

Reply

Same Category

Latest Reply

Announcement

Enthusiastic users today

[Other] Meaningful Endpoints for Idiopathic Pulmonary Fibrosis (IPF) Clinical Trials: Emphasis on 'Feels, Functions, Survives'